Milestone Scientific Inc. (NYSEAMERICAN:MLSS)’s stock price was up 5.1% during trading on Wednesday . The company traded as high as $0.89 and last traded at $0.83, approximately 215,687 shares were traded during mid-day trading. A decline of 19% from the average daily volume of 265,390 shares. The stock had previously closed at $0.79.
Separately, Maxim Group reaffirmed a “buy” rating and issued a $1.00 price objective on shares of Milestone Scientific in a research note on Friday, August 16th.
Milestone Scientific (NYSEAMERICAN:MLSS) last posted its quarterly earnings data on Wednesday, August 14th. The medical instruments supplier reported ($0.02) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.02). The firm had revenue of $2.26 million during the quarter.
About Milestone Scientific (NYSEAMERICAN:MLSS)
Milestone Scientific, Inc develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances.
Further Reading: Quiet Period
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.